- Home
- UONE vs ADVM Comparison
UONE vs ADVM Comparison
Compare UONE & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONE
- ADVM
- Stock Information
- Founded
- UONE 1980
- ADVM 2006
- Country
- UONE United States
- ADVM United States
- Employees
- UONE N/A
- ADVM N/A
- Industry
- UONE Broadcasting
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UONE Consumer Discretionary
- ADVM Health Care
- Exchange
- UONE Nasdaq
- ADVM Nasdaq
- Market Cap
- UONE 68.9M
- ADVM 59.5M
- IPO Year
- UONE N/A
- ADVM 2014
- Fundamental
- Price
- UONE $1.72
- ADVM $2.22
- Analyst Decision
- UONE
- ADVM Strong Buy
- Analyst Count
- UONE 0
- ADVM 5
- Target Price
- UONE N/A
- ADVM $26.40
- AVG Volume (30 Days)
- UONE 29.8K
- ADVM 430.7K
- Earning Date
- UONE 05-13-2025
- ADVM 05-14-2025
- Dividend Yield
- UONE N/A
- ADVM N/A
- EPS Growth
- UONE N/A
- ADVM N/A
- EPS
- UONE N/A
- ADVM N/A
- Revenue
- UONE $437,499,000.00
- ADVM $1,000,000.00
- Revenue This Year
- UONE N/A
- ADVM N/A
- Revenue Next Year
- UONE N/A
- ADVM $42.58
- P/E Ratio
- UONE N/A
- ADVM N/A
- Revenue Growth
- UONE N/A
- ADVM N/A
- 52 Week Low
- UONE $1.23
- ADVM $1.78
- 52 Week High
- UONE $3.33
- ADVM $10.14
- Technical
- Relative Strength Index (RSI)
- UONE 59.78
- ADVM 36.90
- Support Level
- UONE $1.67
- ADVM $2.10
- Resistance Level
- UONE $1.76
- ADVM $2.33
- Average True Range (ATR)
- UONE 0.09
- ADVM 0.24
- MACD
- UONE -0.00
- ADVM 0.03
- Stochastic Oscillator
- UONE 56.52
- ADVM 32.65
About UONE Urban One Inc.
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.